February 18, 2025
TAG Fiercely Condemns the New Administration’s War on Science
Statement / Press
Treatment Action Group (TAG) is disgusted and appalled by the new presidential administration’s flagrant attack on science.
February 14, 2025
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).
February 7, 2025
2025 Pre-CROI Community HIV Cure Research Workshop
Webinar / Presentation
The 2025 Pre-CROI Community HIV Cure Research Workshop will take place on Saturday, March 8 in San Francisco.
February 6, 2025
TAG Joins Allies at State Department to Demand Full Restoration of US Support for Global AIDS Programs
Statement / Press
Treatment Action Group (TAG) fiercely condemns the new presidential administration’s deadly and hateful attack on people living with HIV and their communities at home and around the world.
February 5, 2025
TAG Executive Director Warns: “They Don’t Care If We Live or Die”
This title of this page is one of the quotes by Mark Harrington from his recent appearance on +Life Media with TAG board member Karl Schmid. We rate this video absolutely must watch!
February 4, 2025
Letter Urging Congress to Reject All Proposals to Cut Medicaid
Letter / Comment
TAG was proud to sign on to this 2/3/25 letter created by HIV Health Care Access Working Group (HHCAWG) of the Federal AIDS Policy Partnership (FAPP). It’s addressed to Congressional leaders and urges Congress to adamantly reject all proposals to enact cuts to Medicaid, a vital source of HIV prevention, treatment, and care.
January 29, 2025
Community Surveys Show Enthusiasm for Long-Acting HCV Cure Research
Statement / Press
People living with or at risk of hepatitis C Virus (HCV), health care providers, and policymakers in low- and middle-income countries (LMICs) showed significant interest in a potential long-acting HCV cure, recent surveys have found.
January 22, 2025
TAG Rejects the Transphobia and Science Denialism of the New Presidential Administration
Statement / Press
The new U.S. presidential administration has issued several executive orders, which use pseudo-scientific claims to deny the existence of transgender and non-binary people.
January 21, 2025
TAG Condemns Planned U.S. Withdrawal from WHO
Statement / Press
Treatment Action Group (TAG) is appalled by President Donald Trump’s executive order Monday signaling the United States will be withdrawing from the World Health Organization (WHO).
January 21, 2025
TAG’s Submission to the Office of the High Commissioner for Human Rights (OHCHR)
Letter / Comment
TAG submitted this this input for the Office of the High Commissioner on Human Rights (OHCHR), in response to its request for “Inputs for the comprehensive report, incl. new developments, in ensuring access to medicines, vaccines and other health products.”
December 13, 2024
2024 Report on TB Research Funding Trends
TB R&D Report
A new report released today by Treatment Action Group (TAG) and Stop TB Partnership found that cumulative funding for tuberculosis (TB) research and development (R&D) in 2023 reached only 24% of the annual $5 billion funding target agreed by countries at the United Nations High-Level Meeting (HLM) on TB in September 2023.
December 13, 2024
TB R&D Funding: Billions Short and Reliant on a Few Major Donors, New Report Finds
Statement / Press
A new report released today by Treatment Action Group (TAG) and Stop TB Partnership found that cumulative funding for tuberculosis (TB) research and development (R&D) in 2023 reached only 24% of the annual $5 billion funding target agreed by countries at the United Nations High-Level Meeting (HLM) on TB in September 2023.
December 9, 2024
Cheat Sheets for Tuberculosis Activists
Publication
TAG’s Cheat Sheets for Tuberculosis Activists are designed to help advocates navigate the range of tools in use and in the research pipeline.
November 26, 2024
Community Trainings on Drug-Resistant TB
Webinar / Presentation
To help advocates stay up to date, Treatment Action Group (TAG) organized a series of virtual trainings on the diagnosis, treatment, care and support of people with drug-resistant TB, designed for community and civil society organizations.
November 26, 2024
TAGline November 2024
TAGline
This year’s edition of TAGline takes stock of the state of the HIV, TB, and HCV pandemics worldwide, and advances bold visions for what a future without them must look like.
November 25, 2024
1/4/6×24 Campaign Concerned Prices Hinder Uptake of Important Updated World Health Organization Drug-Resistant TB Treatment Recommendations
Statement / Press
The 1/4/6×24 Campaign warns that regimens to treat drug-resistant TB recently recommended by World Health Organization (WHO) and important diagnostic tools will remain out of reach due to high prices.
November 20, 2024
2024 TAG Update
Publication
As we approach the end of 2024, we want to share with you some of the remarkable progress we’ve made together, and you’ll see some of our work in the 2024 TAG Update.
November 13, 2024
Finally, Children of All Ages Can Benefit from 3HP to Prevent TB!
Statement / Press
The Community Research Advisors Group (CRAG) celebrates both the findings and the methodology of Study 35, a phase I/II clinical trial of the tuberculosis (TB) preventive treatment regimen known as 3HP in children.
November 11, 2024
TAG Statement on the Global Fund and Other Funding Sources to Fight TB, HIV, and Other Pandemics
Statement / Press
In advance of the 52nd Meeting of the Board of the Global Fund to Fight AIDS, Tuberculosis, and Malaria (the Global Fund) and the 2024 Union World Conference on Lung Health, Treatment Action Group (TAG) releases this statement in response to ongoing conversations about the Global Fund’s program allocations for HIV, tuberculosis (TB), and malaria.
October 29, 2024
Statement from TAG’s TB Project on Today’s WHO Global TB Report Release
Statement / Press
Treatment Action Group (TAG) is deeply concerned by the reported decrease in domestic funding for tuberculosis (TB) services announced today in the World Health Organization’s 2024 Global Tuberculosis Report.
October 8, 2024
Gilead Deal to Expand Access to Lenacapavir for PrEP Falls Short
Statement / Press
TAG recognizes Gilead Science’s announcement that it has issued six voluntary licenses to produce generic lenacapavir for distribution within 120 high HIV burden countries as a first step toward broadening access to this potent preventive drug for millions of people at risk of HIV.
September 25, 2024
Statement on the UN High Level Meeting on Antimicrobial Resistance Final Draft Political Declaration
Statement / Press
Treatment Action Group (TAG) congratulates Malta and Barbados, co-facilitators, and all United Nations (UN) Member States participating in the High-Level Meeting on Antimicrobial Resistance (AMR) upon the publication of the final draft of the Political Declaration.
September 16, 2024
2024 Research in Action Awards Celebrate Leaders in Global Health Activism Who Exemplify TAG’s Mission
Statement / Press
Treatment Action Group’s (TAG) most important fundraising event of the year is the Research in Action Awards, which honor the best and brightest activists, researchers, leaders, and scientists whose work has been integral in ending HIV, tuberculosis (TB), and hepatitis C (HCV).
August 14, 2024
Treatment Action Group Calls for Coordinated, Fully Funded Global Response to Mpox Emergency
Statement / Press
Treatment Action Group (TAG) supports the World Health Organization (WHO) in declaring the renewed outbreak of mpox a public health emergency of international concern.
July 25, 2024
TAG Calls for Universal Access to Innovative HCV Testing to End the Disease by 2030
Statement / Press
This World Hepatitis Day, July 28, we are better positioned than ever to end hepatitis C Virus (HCV) as a pandemic.